Portage Biotech (PRTG) Peer Comparison

$4.70

$-0.47 (-9.09%)

As on 05-Nov-2025 09:30EDT

Market cap

$16 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

9.3

Div. Yield

0 %

Edit

	Portage Biotech (PRTG)	Biohaven Pharmaceutical Holding Co (BHVN)
Market cap ($ Mln)	16	2,092
Revenue ($ Mln)	--	--
Net Profit ($ Mln)	-6.77	-586.84
Net Margin (%)	--	--
RoE (%)	-347.11	-1,825.49
Price to Earnings	--	--
Price-To-Book	9.34	166.84

Cashflow
Ratios

Cashflow ($ Mln)

	Portage Biotech (PRTG)	Biohaven Pharmaceutical Holding Co (BHVN)
Cash From Operating Activities	-5.46	-609.44
Cash Flow from Investing Activities	--	300.56
Cash from Financing Activities	2.10	439.12
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Portage Biotech (PRTG)	Biohaven Pharmaceutical Holding Co (BHVN)
ROCE (%)	-342.98	-185.47
ROE (%)	-347.11	-310.75
ROA (%)	-135.29	-138.54
EBIT Margin (%)	--	--
Net Margin (%)	--	--
Cash Profit Margin (%)	--	--

Growth Ratios

	Portage Biotech (PRTG)	Biohaven Pharmaceutical Holding Co (BHVN)
Revenue Growth (%)	--	--
EBIT Growth (%)	--	--
Net Profit Growth (%)	91.02	12.71
EPS Growth (%)	0.92	0.27
Book Value Growth (%)	--	--

Valuation Ratios

	Portage Biotech (PRTG)	Biohaven Pharmaceutical Holding Co (BHVN)
Price / Earnings	-1.47	-1.84
Price / Book Value	-80.92	26.06
Dividend Yield (%)	--	--
EV/EBITDA	--	-1.82
Market Cap ($ Cr)	--	--

Solvency Ratios

	Portage Biotech (PRTG)	Biohaven Pharmaceutical Holding Co (BHVN)
Debt to Equity	--	5.47
Short term debt to equity ratio	--	0.11
Current Ratio	2.02	3.18
Quick Ratio	--	--
Interest Coverage	-2,472.67	--

Operating Efficiency Ratios

	Portage Biotech (PRTG)	Biohaven Pharmaceutical Holding Co (BHVN)
Debtors to sales (%)	--	--
Asset Turnover	0.00	0.00
Receivable days	--	--
Inventory Days	--	--
Payable days	--	1,308.90
Cash Conversion Cycle	--	--

Annual
Quarterly